MIRA
INFORM REPORT
|
Report Date : |
7th
February, 2007 |
IDENTIFICATION
DETAILS
|
Name : |
J.S. ENTERPRISE |
|
|
|
|
Registered Office : |
33-1, Mapo-Dong,
Mapo-Gu,Seoul, Korea |
|
|
|
|
Country : |
Korea |
|
|
|
|
Date of Incorporation : |
2004 |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Pharmaceutical agent and distribution |
RATING & COMMENTS
|
MIRA’s Rating : |
C |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
Status : |
Small
Concern |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
Basic
Information
|
Company Name |
J.S. Enterprise |
|
Address |
33-1, Mapo-Dong,
Mapo-Gu,Seoul, Korea |
|
Building |
#305
Daenong Bldg. |
|
Zip Code |
121-708 |
|
Tel |
+82-2-714-5500 +82-2-717-0471~2 +82-2-717-0493~4 |
|
Fax |
+82-2-717-0964~5 |
|
E-mail |
admin@jsecorp.com;overseas@jsecorp.com |
|
Website |
www.jsecorp.com |
|
Type |
Service |
|
Industry |
Pharmaceutical agent and distribution |
|
Main Business |
Professional Service |
|
Established |
2004 |
Detailed Products
|
Activity |
Detailed
Products (UNSPSC) |
|
Sell |
Pharmaceuticals |
|
Sell |
Health
Care Products |
|
Sell |
Cosmetic
products |
|
Sell |
Fine
chemicals |
Others
|
Name |
N/A |
|
Address |
- |
|
Date of
Birth |
N/A |
|
Title |
Owner |
|
Sex |
N/A |
|
Nationality |
Korean |
|
Capital |
N/A |
|
Employees |
N/A |
|
Formation |
Sole Proprietorship |
The subject’s information is very limited because
it is a sole proprietorship company not having any obligation to open its
information. We contacted the subject for the interview by the phone, but Mr.
Kim Ho-Kon/Staff has rejected to open their information without opening who is
about to know on the company.
Bank
Details
N/A
Corporate
Registered No.
Not Applicable.
Business
Registered No.
N/A
Shareholder Position
The owner has 1005 shares.
Company
History
2004
Established
Products, Technologies, Services
Description
|
Main Products & Services |
Pharmaceuticals - Active pharmaceutical ingredients (APIs) - Finished products - Intermediates Health Care Products - Health foods - Nutrition supplements Cosmetic products - Natural extracts - Synthetic ingredients Fine chemicals |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry
similar weight in credit consideration. Capability to overcome financial
difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|